FI945857A - Immunomääritys - Google Patents

Immunomääritys Download PDF

Info

Publication number
FI945857A
FI945857A FI945857A FI945857A FI945857A FI 945857 A FI945857 A FI 945857A FI 945857 A FI945857 A FI 945857A FI 945857 A FI945857 A FI 945857A FI 945857 A FI945857 A FI 945857A
Authority
FI
Finland
Prior art keywords
immunoassay
Prior art date
Application number
FI945857A
Other languages
English (en)
Swedish (sv)
Other versions
FI945857A0 (fi
Inventor
Richard Julian Stuart Duncan
Urszula Beckford
Original Assignee
Int Murex Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939307732A external-priority patent/GB9307732D0/en
Priority claimed from GB939307659A external-priority patent/GB9307659D0/en
Application filed by Int Murex Tech Corp filed Critical Int Murex Tech Corp
Publication of FI945857A publication Critical patent/FI945857A/fi
Publication of FI945857A0 publication Critical patent/FI945857A0/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI945857A 1993-04-14 1994-12-13 Immunomääritys FI945857A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939307732A GB9307732D0 (en) 1993-04-14 1993-04-14 Assay
GB939307659A GB9307659D0 (en) 1993-04-14 1993-04-14 Assay
PCT/GB1994/000788 WO1994024560A1 (en) 1993-04-14 1994-04-14 Immunoassay

Publications (2)

Publication Number Publication Date
FI945857A true FI945857A (fi) 1994-12-13
FI945857A0 FI945857A0 (fi) 1994-12-13

Family

ID=26302750

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945857A FI945857A0 (fi) 1993-04-14 1994-12-13 Immunomääritys

Country Status (10)

Country Link
EP (1) EP0646241A1 (fi)
JP (1) JPH07508102A (fi)
CN (1) CN1105181A (fi)
AU (1) AU6508694A (fi)
BR (1) BR9404967A (fi)
CA (1) CA2137786A1 (fi)
CZ (1) CZ315094A3 (fi)
FI (1) FI945857A0 (fi)
SK (1) SK153594A3 (fi)
WO (1) WO1994024560A1 (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5801064A (en) * 1995-12-04 1998-09-01 Foresman; Mark D. Assay methods and reagents for detecting autoantibodies
GB9624750D0 (en) * 1996-11-28 1997-01-15 Univ London Capture assays
ES2129358B1 (es) * 1997-04-09 2000-03-16 Vamobi S A Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".
DK1021719T3 (da) * 1997-09-22 2007-06-18 Novartis Vaccines & Diagnostic Fremgangsmåde til påvisning af antistoffer i en pröve
ES2316171T3 (es) 1997-09-22 2009-04-01 Novartis Vaccines And Diagnostics, Inc. Tampones para estabilizar antigenos hcv.
DE59913689D1 (de) † 1998-06-22 2006-08-31 Roche Diagnostics Gmbh Verbesserung von bindeassays durch multiepitopanalyse
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
EP1373896A2 (en) 2001-03-12 2004-01-02 MonoGen, Inc. Cell-based detection and differentiation of disease states
CN100420947C (zh) * 2005-05-30 2008-09-24 孙东旭 用单一捕获剂定量检测特异性分析物的方法及其试剂盒
CN100401066C (zh) * 2005-09-23 2008-07-09 中国人民解放军第三○九医院 基于组合蛋白的结核分枝杆菌金标诊断试剂
WO2008135274A2 (de) * 2007-05-08 2008-11-13 F. Hoffmann-La-Roche Ag Verfahren zum nachweis spezifischer antikörper der immunglobulinklasse g
GB0815675D0 (en) * 2008-08-28 2008-10-08 Mabtech Ab Antibody secreting cell elispot
CN101858916A (zh) * 2010-05-19 2010-10-13 厦门大学附属中山医院 梅毒特异性IgM抗体胶体金免疫层析检测试剂条及其制备方法
CN103364551A (zh) * 2012-04-01 2013-10-23 武汉中博生物股份有限公司 猪繁殖与呼吸综合征病毒IgM抗体ELISA检测试剂盒及其制备方法和其应用
CN103364552A (zh) * 2012-04-01 2013-10-23 武汉中博生物股份有限公司 猪细小病毒IgM抗体ELISA检测试剂盒及其制备方法和其应用
CN102998441A (zh) * 2012-11-20 2013-03-27 哈德逊（天津）生物技术有限责任公司 快速检测诱导性多潜能干细胞的试剂盒
CN103018446B (zh) * 2012-12-24 2014-08-20 青岛汉唐生物科技有限公司 用于检测甲型肝炎病毒抗体的方法、检测用的试剂盒及其制备方法
CN103940991B (zh) * 2013-03-15 2016-03-16 河南省农业科学院 猪沙门氏菌耐热毒素快速检测试纸条
WO2014176535A1 (en) 2013-04-26 2014-10-30 Bio-Rad Laboratories, Inc. Multiplex hepatitis b assay
CN103267846A (zh) * 2013-06-09 2013-08-28 湖南农业大学 一种检测2型猪圆环病毒IgM抗体的ELISA试剂盒
NL2017204B1 (en) 2016-06-08 2017-12-18 Kei International Ltd Solid substrate comprising antigens immobilised thereto, biosensor comprising said solid substrate and method for detecting the presence of mycobacterial material in a sample
EP3258267A1 (en) * 2016-06-13 2017-12-20 Siemens Healthcare GmbH Method to detect infections and serological status of humans or animals
DE102018214872A1 (de) * 2018-08-31 2020-03-05 Genome Identification Diagnostics Gmbh Verfahren zur in vitro Diagnose und/oder in vitro Therapieverfolgung einer Infektion und/oder Krankheit, insbesondere Infektionskrankheit, und/oder Tumorerkrankung und/oder Autoimmunerkrankung und/oder Allergie und/oder zur Impfkontrolle und/oder zum Nachweis einer Kreuzprotektivität sowie Verwendung eines Kits in einem solchen Verfahren
NL2022166B1 (en) * 2018-12-10 2020-07-02 Kei International Ltd Nitrocellulose sheet comprising immobilized immunoglobulins and lipid based antigens and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273756A (en) * 1978-07-28 1981-06-16 Abbott Laboratories Immunoassay for class specific antibodies
GB8707839D0 (en) * 1987-04-02 1987-05-07 Secr Social Service Brit Immunoglobulin assay method
WO1989012231A1 (en) * 1988-06-08 1989-12-14 Cambridge Bioscience Corporation Anti-fc assay for detection of antibodies
US5075077A (en) * 1988-08-02 1991-12-24 Abbott Laboratories Test card for performing assays
CA2008100A1 (en) * 1989-01-20 1990-07-20 Hubert Bayer Method for the determination of immunologically detectable substance
WO1991008485A1 (en) * 1989-12-01 1991-06-13 Pb Diagnostic Systems, Inc. Immunoassay for antibodies to infectious disease agents
IE904365A1 (en) * 1990-02-13 1991-08-14 Epitope Stick probe device for detection of antibodies
DE59109221D1 (de) * 1990-11-03 2001-11-15 Dade Behring Marburg Gmbh HCV-spezifische Peptide, Mittel dazu und ihre Verwendung

Also Published As

Publication number Publication date
AU6508694A (en) 1994-11-08
SK153594A3 (en) 1995-07-11
CA2137786A1 (en) 1994-10-27
WO1994024560A1 (en) 1994-10-27
JPH07508102A (ja) 1995-09-07
EP0646241A1 (en) 1995-04-05
CZ315094A3 (en) 1996-01-17
FI945857A0 (fi) 1994-12-13
CN1105181A (zh) 1995-07-12
BR9404967A (pt) 1999-06-15

Similar Documents

Publication Publication Date Title
DK0574782T3 (da) Dobbeltanalyt-immunassay
DK145493D0 (da) Antistof
FI955652A0 (fi) Kehruukenno
NO962456D0 (no) Anti-begroningsmiddel
FI961590A0 (fi) Kattotuuletuslaite
FI945857A (fi) Immunomääritys
FI932791A0 (fi) Kauhamurskain
ATA146094A (de) Windsichter
NO944870L (no) Resonansabsorbator
FI102671B1 (fi) Hengenpelastuskelluke
ATA212793A (de) Sportschuh
ATA194593A (de) Sportschuh
FI930971A0 (fi) Telekommunikationsapparat
ATA179094A (de) Kettenschloss
BR7302292U (pt) Classitudo
FI1180U1 (fi) Avfallsbehaollarsystem
FI827U1 (fi) Anordning foer koettbehandling
FI1148U1 (fi) Utomhuseld
FI1084U1 (fi) Foerhoejningslaemmar foer en skottkaerra
FI1033U1 (fi) Griplaos foer en nerifraon uppaot fungerande rullgardin
FI959U1 (fi) Takspridare foer tilluft
ATE144907T1 (de) Rollbrett
FI933076A0 (fi) Foerflyttbar husbehovssaog
FIU930388U0 (fi) Isolerbox
SE9302374L (sv) Lågformstativ

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: MUREX DIAGNOSTICS CORPORATION